Situation: Our client wanted to increase their appeal and value to payers by developing innovative therapeutic category cost management strategies. The client also wanted to prepare the market for new product launches that would benefit from continued open access in the category.
CRA contribution: Market research with KOLs in the payer community allowed CRA to identify key payer concerns and unmet needs, which ultimately informed a comprehensive category management approach that AEs could take to their customers.
Result: CRA delivered innovative management solutions to payer customers, encouraging payers to focus on greatest opportunities for cost savings rather than short-term gains from higher rebates.
Counting the cost of carbon to shareholders: Taking first steps
Companies are facing the prospect of being taxed on greenhouse gas (GHG) emissions, which could reduce profitability and, ultimately, shareholder value. Our...